21 May 2013
Keywords: strong, data, crestor, updated, guidelines, anglo-swedish, drug
Article | 22 May 2006
Anglo-Swedish drug major AstraZeneca says that results from the MERCURY II trial, published in the on-line May issue of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 May 2006
20 May 2013
© 2013 thepharmaletter.com